The short answer
Cascara can lower potassium if it causes substantial diarrhea or is used excessively. Low potassium can increase clozapine’s heart-rhythm risk. Clozapine has not been shown to make cascara deplete potassium more strongly. Cascara is included in some clinician-directed constipation guidance, so this is not a blanket prohibition of managed treatment.
What this answer covers
Oral laxative-active Frangula purshiana bark preparations, including standardized cascara bark tea or extracts.
- Supplement or preparation
- Frangula purshiana
- Medication ingredient
- clozapine
What the potassium concern means
The relevant chain is laxative-related diarrhea or excessive use, potassium loss, and greater susceptibility to heart-rhythm problems during clozapine treatment. It is not evidence that routine co-use automatically produces low potassium.
Constipation treatment still matters
Clozapine constipation needs active treatment. New York guidance lists cascara among stimulant options, but this does not establish that it is the best choice for everyone. Ask your clozapine team which product, dose and duration fit your bowel plan.
Use the exact product and report changes
Avoid adding extra cascara teas, extracts or tablets on top of prescribed laxatives without checking the total dose. Tell your team about sustained watery stools, weakness, reduced intake or dehydration. They can decide whether potassium, magnesium or heart-rhythm testing is needed. Do not start potassium supplements or change clozapine yourself.
When to seek urgent care
Seek urgent help for fainting or new palpitations, or for abdominal pain with swelling or vomiting. Watery stool can also pass around an impaction. These symptoms need assessment before assuming that more laxative or simply stopping a bowel regimen is the answer.
Evidence and practical considerations
Side effects & toxicity
Cascara-related diarrhea or excessive laxative use can lower potassium, making clozapine-associated QT risk more concerning.
- Exact scope
- Oral laxative-active Frangula purshiana bark preparations, including standardized cascara bark tea or extracts. with Oral clozapine (RxNorm IN 2626)
- Medication form and route
- Oral clozapine with oral supplement
- Timing or duration
- Depends on preparation, exposure and bowel function.
What remains uncertain
- Indirect combination of botanical labeling and clozapine electrolyte warning. No exact-pair study demonstrating additional potassium depletion by clozapine or quantifying arrhythmia incidence.
Factors that may matter: Persistent diarrhea; Excessive laxative use; Other potassium-lowering medicines; Existing low potassium or magnesium; Cardiac disease.
Read the supporting source summaries
Source 1: regulatory_label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral clozapine
Warns that additional anticholinergic activity raises risk of severe gut hypomotility complications. Low potassium or magnesium increases QT risk; diarrhea can lower potassium. Recommends bowel monitoring and appropriate laxatives.
How this applies: Direct clozapine safety guidance; botanical application requires separate exposure evidence.
No exact botanical product studied and no pair-specific incidence.
Source 2: regulatory_monograph
ema.europa.eu · Source check Sep 10, 2026
Population: Users of standardized cascara bark medicines
Long-term laxative abuse can cause hypokalemia. Overdose may cause diarrhea and electrolyte loss; QT-prolonging medicines warrant prescriber consultation.
How this applies: Explicitly identifies Frangula purshiana as synonym of Rhamnus purshiana. Applies to laxative-active bark preparations.
No controlled clozapine co-use data or incidence; ordinary supervised dosing is distinct from abuse.
Research assessment: · Open full citations ↗
Timing & monitoring
Cascara is named as one stimulant option in clinician-directed clozapine constipation guidance.
- Exact scope
- Oral laxative-active Frangula purshiana bark preparations, including standardized cascara bark tea or extracts. with Oral clozapine (RxNorm IN 2626)
- Medication form and route
- Oral clozapine with oral supplement
- Timing or duration
- Depends on preparation, exposure and bowel function.
What remains uncertain
- Guidance is not a controlled cascara-specific benefit or safety study.
Read the supporting source summaries
Source 1: clinical_guidance
omh.ny.gov · Source check Sep 10, 2026
Population: People treated with clozapine
Lists senna and cascara among stimulant options; advises avoiding bulk supplements and urgent assessment of severe problems or nausea/vomiting.
How this applies: Direct practice context for clinician-directed cascara use, preventing an unsupported blanket prohibition.
Undated brief guidance; not proof of cascara efficacy or safety in a controlled exact-pair trial.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Draft prepared from prescribing information, botanical evidence and constipation guidance. | |
| Research summary published |
Article revision: 7398ea3a1b5cb731
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.